FDA mulls compounding for peptides previously flagged over safety risks BioSpace BPC 157: What you need to know before you try it You are hearing more about BPC 157. Patients ask about it daily. Here are the most common questions answered. What is BPC 157? BPC 157 The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Early evidence suggests BPC 157 repairs tissue rather than just dulling symptoms. To read more, tap the link in bio.